Bergenbio ASA (BGBIO) - Cash Flow Conversion Efficiency

Latest as of December 2024: -1.249x

Based on the latest financial reports, Bergenbio ASA (BGBIO) has a cash flow conversion efficiency ratio of -1.249x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-153.24 Million ≈ $-16.13 Million USD) by net assets (Nkr122.70 Million ≈ $12.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bergenbio ASA net asset quality index to measure how much of total assets are equity-financed.

Bergenbio ASA - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Bergenbio ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Bergenbio ASA (BGBIO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Bergenbio ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bergenbio ASA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dongyang S.Tec Co.Ltd KQ:060380	-0.075x
Nelson Resources Ltd AU:NES	-0.099x
Stavely Minerals Ltd AU:SVY	-0.194x
KWESST MICRO SYS.INC. F:62UA	-0.430x
Search Minerals Inc V:SMY	-0.011x
Semacom Integrated Tbk PT JK:SEMA	0.010x
Zaklady Urzadzen Kotlowych Staporkow SA WAR:ZUK	0.028x
Birks Group Inc NYSE MKT:BGI	0.210x

Annual Cash Flow Conversion Efficiency for Bergenbio ASA (2014–2024)

The table below shows the annual cash flow conversion efficiency of Bergenbio ASA from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Bergenbio ASA worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Nkr122.70 Million ≈ $12.91 Million	Nkr-153.24 Million ≈ $-16.13 Million	-1.249x	+43.24%
2023-12-31	Nkr127.48 Million ≈ $13.41 Million	Nkr-280.50 Million ≈ $-29.52 Million	-2.200x	+32.44%
2022-12-31	Nkr88.50 Million ≈ $9.31 Million	Nkr-288.23 Million ≈ $-30.33 Million	-3.257x	-312.75%
2021-12-31	Nkr384.43 Million ≈ $40.45 Million	Nkr-303.34 Million ≈ $-31.92 Million	-0.789x	-125.73%
2020-12-31	Nkr670.23 Million ≈ $70.53 Million	Nkr-234.29 Million ≈ $-24.65 Million	-0.350x	+58.28%
2019-12-31	Nkr219.75 Million ≈ $23.12 Million	Nkr-184.15 Million ≈ $-19.38 Million	-0.838x	-51.38%
2018-12-31	Nkr337.28 Million ≈ $35.49 Million	Nkr-186.71 Million ≈ $-19.65 Million	-0.554x	-15.37%
2017-12-31	Nkr350.35 Million ≈ $36.87 Million	Nkr-168.11 Million ≈ $-17.69 Million	-0.480x	+40.84%
2016-12-31	Nkr153.27 Million ≈ $16.13 Million	Nkr-124.31 Million ≈ $-13.08 Million	-0.811x	+16.51%
2015-12-31	Nkr64.75 Million ≈ $6.81 Million	Nkr-62.90 Million ≈ $-6.62 Million	-0.972x	-155.71%
2014-12-31	Nkr141.38 Million ≈ $14.88 Million	Nkr-53.72 Million ≈ $-5.65 Million	-0.380x	--

About Bergenbio ASA

OL:BGBIO Norway Biotechnology

Market Cap

$7.75 Million

Nkr73.62 Million NOK

Market Cap Rank

#27657 Global

#248 in Norway

Share Price

Nkr0.47

Change (1 day)

-5.91%

52-Week Range

Nkr0.47 - Nkr1.24

All Time High

Nkr4414.96